Top 5 S&P 500 healthcare performers in Q3: Bristol-Myers Squibb (BMY) +30.78% Solventum (SOLV) +30.43% HCA Healthcare (HCA) +26.82% ResMed (RMD) +26.09% Waters Corporation (WAT) +25.96% Bristol ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Options Corner: Political Turmoil Sets Up A Contrarian Call Spread For Bristol-Myers Squibb Although the Trump administration's healthcare policies pose risks for Bristol-Myers Squibb, the chaos ...

A look at the shareholders of Bristol-Myers Squibb Company (NYSE:BMY) can tell us which group is most powerful. With 81% ...

Bristol Myers Squibb said it will slash $2 billion in costs by the end of 2027, expanding its ongoing cost-savings effort to ...

Let's delve deeper into each type of owner of Bristol-Myers Squibb, beginning with the chart below. Many institutions measure their performance against an index that approximates the local market.

After revealing in February plans to save $2 billion more on top of a previously disclosed cost-cutting initiative, Bristol Myers Squibb is conducting another round of job cuts in the Garden State.

The following chart shows its quarterly free cash flow less its dividend payments, which has often been more than $1 billion. Bristol Myers' dividend looks safe, despite what may have looked like ...